CVE-2018-1801

Description

IBM App Connect V11.0.0.0 through V11.0.0.1, IBM Integration Bus V10.0.0.0 through V10.0.0.13, IBM Integration Bus V9.0.0.0 through V9.0.0.10, and WebSphere Message Broker V8.0.0.0 through V8.0.0.9 is vulnerable to a XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to consume memory resources. IBM X-Force ID: 149639.

Category

5.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.27%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Integration Bus
Affected: IBM WebSphere Message Broker
Affected: IBM App Connect
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/149639 vdb entry vendor advisory
http://www.ibm.com/support/docview.wss?uid=ibm10795780 patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2018-1801?
CVE-2018-1801 has been scored as a medium severity vulnerability.
How to fix CVE-2018-1801?
To fix CVE-2018-1801, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-1801 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-1801 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-1801?
CVE-2018-1801 affects IBM Integration Bus, IBM WebSphere Message Broker, IBM App Connect.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.